S98 Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis (IPF) under pirfenidone treatment

M Kreuter; P Spagnolo; W Wuyts; E Renzoni; D Koschel; F Bonella; TM Maher; M Kolb; D Weycker; K Kirchgässler; U Costabel

doi:10.1136/thoraxjnl-2016-209333.104

Article info

Idiopathic Pulmonary Fibrosis Therapy

S98 Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis (IPF) under pirfenidone treatment

Authors

M Kreuter 1Pneumology and Respiratory Critical Care Medicine, Centre for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Heidelberg, Germany and Translational Lung Research Centre Heidelberg (TLRCH), German Centre for Lung Research (DZL), Heidelberg, Germany PubMed articles Google scholar articles
P Spagnolo 2Section of Respiratory Diseases; Department of Cardiac, Thoracic and Vascular Sciences; University of Padua, Padua, Italy PubMed articles Google scholar articles
W Wuyts 3Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals, Leuven, Belgium PubMed articles Google scholar articles
E Renzoni 4National Institute for Health Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute Imperial College, London, UK PubMed articles Google scholar articles
D Koschel 5Department of Pulmonary Diseases, Fachkrankenhaus Coswig, Centre for Pulmonary Diseases and Thoracic Surgery, Coswig, Germany PubMed articles Google scholar articles
F Bonella 6Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany PubMed articles Google scholar articles
TM Maher 4National Institute for Health Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute Imperial College, London, UK PubMed articles Google scholar articles
M Kolb 7Firestone Institute for Respiratory Health, Department of Medicine, Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada PubMed articles Google scholar articles
D Weycker 8Policy Analysis Inc. (PAI), MINERVA Health Economics Network, Ltd., Brookline, MA, USA PubMed articles Google scholar articles
K Kirchgässler 9F. Hoffmann-La Roche Ltd, Basel, Switzerland PubMed articles Google scholar articles
U Costabel 6Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany PubMed articles Google scholar articles

Citation

Kreuter M, Spagnolo P, Wuyts W, et al

S98 Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis (IPF) under pirfenidone treatment

Thorax 2016;71:A58.

Publication history

First published November 15, 2016.

Online issue publication

September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password